Gartner, Inc.

(New York Stock Exchange)
Back to all articles
Somewhat Bearish -35

Counterpoint Mutual Funds LLC Purchases New Stake in Gartner, Inc. $IT

AI-generated analysis

πŸ“ˆ Counterpoint Mutual Funds LLC acquired 3,682 shares of Gartner in Q1 valued at approximately $583,000.

πŸ“‰ Barclays lowered its price objective from $180.00 to $150.00 and assigned an 'equal weight' rating.

πŸ“‰ UBS Group cut its target price from $170.00 to $164.00 with a 'neutral' rating.

πŸ“‰ Wells Fargo & Company reduced its price target to $120.00 and set an 'underweight' rating.

πŸ’° Gartner reported Q1 EPS of $3.32, beating the consensus estimate of $2.99 by $0.33.

πŸ“‰ Revenue for the quarter was $1.49 billion, missing the consensus estimate of $1.51 billion.

πŸ“‰ Year-over-year revenue declined by 1.5% during the reported quarter.

πŸ“Š The company achieved a return on equity of 161.39% and a net margin of 11.44%.

πŸ“ˆ Institutional ownership remains high at 91.51% across hedge funds and mutual funds.

πŸ“‰ Shares opened at $136.08, trading below the 200-day simple moving average of $174.98.

Bullish Signals
  • Gartner beat earnings expectations with EPS of $3.32 versus a consensus estimate of $2.99.
  • The company maintains a robust return on equity of 161.39% and a healthy net margin of 11.44%.
  • Institutional ownership is strong at 91.51%, with Counterpoint Mutual Funds adding a significant $583,000 stake in Q1.
  • Analysts anticipate FY 2026 EPS of 13.65, which exceeds the company's own guidance of 13.25.
Risk Factors
  • Revenue declined 1.5% year-over-year to $1.49 billion, missing analyst consensus estimates.
  • Multiple major analysts have lowered price targets, including Barclays ($180 to $150), UBS ($170 to $164), and Wells Fargo ($140 to $120).
  • The stock is trading below its 200-day simple moving average of $174.98, indicating potential short-term weakness.
  • Weiss Ratings maintains a 'sell' rating on the company's shares.
Full Analysis
Counterpoint Mutual Funds LLC acquired a new stake in Gartner, Inc. (NYSE:IT) during the first quarter, purchasing 3,682 shares valued at approximately $583,000. Other institutional investors also adjusted their positions recently; Physician Wealth Advisors Inc. increased its holdings by 143.9% to own 100 shares worth $25,000, while DV Equities LLC and Entrust Financial LLC added new stakes valued around $25,000-$26,000 each in the fourth quarter. Analyst sentiment remains mixed with several major firms lowering their price targets. Barclays reduced its objective from $180 to $150 with an 'equal weight' rating, while UBS Group cut its target to $164 and Wells Fargo lowered it to $120 with an 'underweight' rating. Royal Bank of Canada adjusted its target to $160, and Weiss Ratings maintained a sell designation despite a slight downgrade in severity. Gartner reported earnings on May 5th, posting $3.32 EPS which beat the consensus estimate of $2.99, though revenue of $1.49 billion missed expectations by $20 million and declined 1.5% year-over-year. The company maintains a strong return on equity of 161.39% and a net margin of 11.44%, with analysts currently anticipating FY 2026 EPS of 13.65 compared to the company's guidance of 13.25. Shares of IT opened at $136.08, trading below its 200-day simple moving average of $174.98 but above its 50-day average of $148.89. The stock has a market capitalization of $9.11 billion and a P/E ratio of 13.45. Institutional ownership stands at 91.51%, indicating significant interest from hedge funds and mutual funds despite recent analyst downgrades.